Patil S, Singh P, Maibach H
Department of Dermatology, School of Medicine, University of California, San Francisco 94143-0989, USA.
Pharm Res. 1995 Dec;12(12):2018-23. doi: 10.1023/a:1016220712717.
Since topical application of sodium lauryl sulfate (SLS) has been reported to elevate transepidermal water loss and decrease skin capacitance in areas immediately adjacent to the applied site, studies were carried out to quantify the extent of radial spread of SLS below a topically exposed site in a hairless rat model.
Fixed sites were demarcated and the levels of SLS measured around the applied site in the epidermis, dermis and the subcutaneous tissues. Underlying deep tissue penetration and radial spread of SLS in the presence and absence of a vasoconstrictor, phenylephrine, was also quantified.
In a typical 24 hour study, the radial spread of SLS was observed to a distance of approximately 0.75 cm from the applied site. The use of phenylephrine (1:20000), did not significantly enhance either the local underlying tissue (apart from underlying epidermis) concentration or radial spread of SLS relative to no vasoconstrictor treatment.
Given that SLS impairs barrier function of the skin, its radial spread could be explained by a passive diffusion process. Vasoconstrictor did not remarkably alter SLS penetration and radial spread possibly due to the competing effects of vasodilation (caused by SLS) and vasoconstriction (caused by phenylephrine).
由于据报道,局部应用月桂醇硫酸酯钠(SLS)会导致经皮水分流失增加,并使紧邻涂抹部位的皮肤电容降低,因此开展了相关研究,以量化在无毛大鼠模型中,SLS在局部暴露部位下方的径向扩散程度。
划定固定部位,并测量涂抹部位周围表皮、真皮和皮下组织中的SLS水平。还对在有和没有血管收缩剂去氧肾上腺素存在的情况下,SLS在深层组织中的渗透及径向扩散进行了量化。
在一项典型的24小时研究中,观察到SLS从涂抹部位径向扩散至约0.75厘米的距离。与未使用血管收缩剂治疗相比,使用去氧肾上腺素(1:20000)并未显著提高局部深层组织(除底层表皮外)中SLS的浓度或其径向扩散程度。
鉴于SLS会损害皮肤屏障功能,其径向扩散可能是由被动扩散过程所致。血管收缩剂并未显著改变SLS的渗透和径向扩散,这可能是由于(SLS引起的)血管舒张和(去氧肾上腺素引起的)血管收缩的相互竞争作用。